Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cardiol Therapeutics Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 32 | 35 | +3 |
| Shares | 6.92M | 6.55M | −361.7K (−5.2%) |
| Value | $6.02M | $11.7M | +$5.73M (+95.2%) |
New holders (6)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 60,398 | $109.3K | 0.00% |
| Susquehanna International Group, LLP | 45,669 | $82.7K | 0.00% |
| Envestnet Asset Management Inc | 25,380 | $45.7K | 0.00% |
| Two Sigma Securities, LLC | 14,681 | $26.6K | 0.00% |
| TownSquare Capital, LLC | 12,661 | $22.9K | 0.00% |
| Wells Fargo & Company | 3,000 | $5.38K | 0.00% |
Sold out (3)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| AXS Investments LLC | 697,651 | $579.2K |
| Advisory Services Network, LLC | 3,458 | $2.92K |
| Federation des caisses Desjardins du Quebec | 1,800 | $1.50K |